Vance Albaugh
Last active: 1/4/2019

Arginine-Dual roles as an onconutrient and immunonutrient.

Albaugh VL, Pinzon-Guzman C, Barbul A
J Surg Oncol. 2017 115 (3): 273-280

PMID: 27861915 · PMCID: PMC6486789 · DOI:10.1002/jso.24490

Arginine is an important player in numerous biologic processes and studies have demonstrated its importance for cellular growth that becomes limiting in states of rapid turnover (e.g., malignancy). Thus, arginine deprivation therapy is being examined as an adjuvant cancer therapy, however, arginine is also necessary for immune destruction of malignant cells. Herein we review the data supporting arginine deprivation or supplementation in cancer treatment and the currently registered trials aimed at understanding these divergent strategies. J. Surg. Oncol. 2017;115:273-280. © 2016 Wiley Periodicals, Inc.

© 2016 Wiley Periodicals, Inc.

MeSH Terms (5)

Animals Arginine Dietary Supplements Humans Neoplasms

Connections (1)

This publication is referenced by other Labnodes entities: